Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04587856
NA

Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto

View on ClinicalTrials.gov

Summary

This is a biological study for adult MDS patients who undergo HSCT procedure. Viable bone marrow samples will be collected and cryopreserved from MDS patients before transplantation and at clinical disease recurrence. CD34+ blast cells at disease relapse after HSCT will be compared with CD34+ cells collected before transplant to study genomic and transcriptomic changes.

Official title: Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

38

Start Date

2021-02-12

Completion Date

2025-03

Last Updated

2024-10-22

Healthy Volunteers

No

Interventions

OTHER

bone marrow withdrawal

bone marrow samples evaluation

Locations (7)

Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto

Bari, Italy

Unità di Ricerca e di Malattie del sangue - Ematologia S. Luca Vecchio

Florence, Italy

AOU San Martino-IST-Ematologia 1

Genova, Italy

Sezione di Ematologia - Ospedale S.Maria della Misericordia

Perugia, Italy

Dip. di Medicina Trasl. E di Precisione - U.O.C. Ematologia

Roma, Italy

Policlinico Tor Vergata

Roma, Italy

Ististuto Clinico Humanitas - Rozzano - Uo Oncologia Medica Ed Ematologia

Rozzano, Italy